These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8513399

  • 41. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
    Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, Yamadori A.
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
    [Abstract] [Full Text] [Related]

  • 42. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K.
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [Abstract] [Full Text] [Related]

  • 43. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.
    Nochlin D, van Belle G, Bird TD, Sumi SM.
    Alzheimer Dis Assoc Disord; 1993 Oct; 7(4):212-22. PubMed ID: 8305189
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
    Fabelo N, Martín V, Marín R, Moreno D, Ferrer I, Díaz M.
    Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
    [Abstract] [Full Text] [Related]

  • 47. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
    van Helmond ZK, Miners JS, Bednall E, Chalmers KA, Zhang Y, Wilcock GK, Love S, Kehoe PG.
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
    [Abstract] [Full Text] [Related]

  • 48. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer's Disease.
    Obis E, Sol J, Andres-Benito P, Martín-Gari M, Mota-Martorell N, Galo-Licona JD, Piñol-Ripoll G, Portero-Otin M, Ferrer I, Jové M, Pamplona R.
    Aging Dis; 2023 Oct 01; 14(5):1887-1916. PubMed ID: 37196109
    [Abstract] [Full Text] [Related]

  • 49. Free D-aspartate and D-alanine in normal and Alzheimer brain.
    Fisher GH, D'Aniello A, Vetere A, Padula L, Cusano GP, Man EH.
    Brain Res Bull; 1991 Jun 01; 26(6):983-5. PubMed ID: 1933416
    [Abstract] [Full Text] [Related]

  • 50. On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease.
    Ross BM, Knowler JT, McCulloch J.
    J Neurochem; 1992 May 01; 58(5):1810-9. PubMed ID: 1560235
    [Abstract] [Full Text] [Related]

  • 51. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material.
    Danscher G, Jensen KB, Frederickson CJ, Kemp K, Andreasen A, Juhl S, Stoltenberg M, Ravid R.
    J Neurosci Methods; 1997 Sep 05; 76(1):53-9. PubMed ID: 9334939
    [Abstract] [Full Text] [Related]

  • 52. D-aspartate in human brain.
    Man EH, Fisher GH, Payan IL, Cadilla-Perezrios R, Garcia NM, Chemburkar R, Arends G, Frey WH.
    J Neurochem; 1987 Feb 05; 48(2):510-5. PubMed ID: 3794720
    [Abstract] [Full Text] [Related]

  • 53. Brain aluminum in aging and Alzheimer disease.
    McDermott JR, Smith AI, Iqbal K, Wisniewski HM.
    Neurology; 1979 Jun 05; 29(6):809-14. PubMed ID: 572003
    [Abstract] [Full Text] [Related]

  • 54. Free D-serine concentration in normal and Alzheimer human brain.
    Nagata Y, Borghi M, Fisher GH, D'Aniello A.
    Brain Res Bull; 1995 Jun 05; 38(2):181-3. PubMed ID: 7583345
    [Abstract] [Full Text] [Related]

  • 55. THE 2-HYDROXY FATTY ACIDS IN WHITE MATTER OF INFANT AND ADULT BRAINS.
    ENG LF, GERSTL B, HAYMAN RB, LEE YL, TIETSORT RW, SMITH JK.
    J Lipid Res; 1965 Jan 05; 6():135-9. PubMed ID: 14280460
    [No Abstract] [Full Text] [Related]

  • 56. Fatty acids of white matter of human brain.
    GERSTL B, HAYMAN RB, TAVASTSTJERNA MG, SMITH JK.
    Experientia; 1962 Mar 15; 18():131-3. PubMed ID: 13898088
    [No Abstract] [Full Text] [Related]

  • 57. Detecting early changes in Alzheimer's disease with graph theory.
    Pereira JB.
    Brain Commun; 2020 Mar 15; 2(2):fcaa129. PubMed ID: 33225274
    [Abstract] [Full Text] [Related]

  • 58. Diagnosis of Inflammation of the Grey, and the White Matter of the Brain.
    West J Med Surg; 1842 Mar 15; 5(3):206-207. PubMed ID: 38207876
    [No Abstract] [Full Text] [Related]

  • 59. Commentary: At least eighty percent of brain grey matter is modifiable by physical activity: a review study.
    Esteban-Cornejo I, Catena A, Hillman CH, Kramer AF, Erickson KI, Ortega FB.
    Front Hum Neurosci; 2018 Mar 15; 12():195. PubMed ID: 29867418
    [No Abstract] [Full Text] [Related]

  • 60. Notes of the Chemical Composition and Microscopical Characters of the Liver and Kidney in Some Cases of Diabetes, More Particularly with Reference to the Amount of Fatty Matter Present in These Glands.
    Beale L.
    Br Foreign Med Chir Rev; 1853 Jul 15; 12(23):226-233. PubMed ID: 30164536
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.